Concepedia

Ricklie Julian

RJ

Statistics

Publications

12

Citations

396

H-Index

11

Active since

2015

Affiliations

University of Arizona(Current)

Emory University

Washington University in St. Louis

MUSC Hollings Cancer Center

Yale Cancer Center

Ricklie Julian is an author at University of Arizona specializing in oncology, cancer immunotherapy, and medicine.

Publications per year

2015–2025

12

Publications

12

T-cell Responses to Individualized Neoantigen Therapy mRNA-4157 (V940) Alone or in Combination with Pembrolizumab in the Phase 1 KEYNOTE-603 Study

Justin F. Gainor, Manish R. Patel, Jeffrey S. Weber et al. · Cancer Discovery · 2024 · 100 citations

Medicine, Immunology, Oncology +17

Tell Me Your Story: A Pilot Narrative Medicine Curriculum During the Medicine Clerkship

Katherine C. Chretien, Rebecca R. Swenson, Bona Yoon et al. · Journal of General Internal Medicine · 2015 · 64 citations · Full text

Medicine, Curriculum, Medical Education +7

798 Safety, tolerability, and immunogenicity of mRNA-4157 in combination with pembrolizumab in subjects with unresectable solid tumors (KEYNOTE-603): an update

Julie E. Bauman, Howard A. Burris, Jeffrey Clarke et al. · 2020 · 54 citations · Full text

Life Sciences, Immunology, Oncology +17

Randomized Phase II Trial of Ficlatuzumab With or Without Cetuximab in Pan-Refractory, Recurrent/Metastatic Head and Neck Cancer

Julie E. Bauman, Nabil F. Saba, Denise J. Roe et al. · Journal of Clinical Oncology · 2023 · 48 citations · Full text

Medicine, Oncology, Pharmacology +17

71P A phase II study of ADU-S100 in combination with pembrolizumab in adult patients with PD-L1+ recurrent or metastatic HNSCC: Preliminary safety, efficacy and PK/PD results

Dan P. Zandberg, Robert L. Ferris, Douglas Laux et al. · Annals of Oncology · 2020 · 32 citations

Medicine, Oncology, Pharmacology +14

1–5 of 12